Oleg Demin

1.4k total citations
49 papers, 1.1k citations indexed

About

Oleg Demin is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Oleg Demin has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Physiology and 9 papers in Oncology. Recurrent topics in Oleg Demin's work include Computational Drug Discovery Methods (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Mitochondrial Function and Pathology (5 papers). Oleg Demin is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Mitochondrial Function and Pathology (5 papers). Oleg Demin collaborates with scholars based in Russia, United States and United Kingdom. Oleg Demin's co-authors include Igor Goryanin, Alexander Mazein, Anatoly Sorokin, Hongwu Ma, E Selkov, Kirill Peskov, Boris Ν. Kholodenko, Jan B. Hoek, Balaji Agoram and Vida Mildažienė and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Oleg Demin

49 papers receiving 1.0k citations

Peers

Countries citing papers authored by Oleg Demin

Since Specialization

Citations

This map shows the geographic impact of Oleg Demin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg Demin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg Demin more than expected).

Fields of papers citing papers by Oleg Demin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleg Demin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg Demin. The network helps show where Oleg Demin may publish in the future.

Co-authorship network of co-authors of Oleg Demin

This figure shows the co-authorship network connecting the top 25 collaborators of Oleg Demin. A scholar is included among the top collaborators of Oleg Demin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleg Demin. Oleg Demin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology 2025 ·Drug Discovery Today ·Igor Goryanin, Oleg Demin	2
2	Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B‐Cell Malignancies 2025 ·CPT Pharmacometrics & Systems Pharmacology ·Oleg Demin, Ying Ou, (unknown), (unknown), Alexander A. Stepanov, (unknown), (unknown), (unknown), (unknown), Zhiyu Tang, William D. Hanley	1
3	338 Comparison of lymphodepleting chemotherapy regimens as preconditioning for T-cell therapies 2023 ·SHILAP Revista de lepidopterología ·Oleg Demin, (unknown), Natalia Ramos-Hernández, Thomas Faitg, Stefan Zajic, L. Cucurull-Sanchez	2
4	354 Optimization of dose and regimen of letetresgene autoleucel for the treatment of synovial sarcoma: simulation of dose dependence and split dosing using quantitative systems pharmacology modeling 2023 ·SHILAP Revista de lepidopterología ·Oleg Demin, (unknown), Stefan Zajic, L. Cucurull-Sanchez	1
5	CYTOCON: The manually curated database of human in vivo cell and molecule concentrations 2022 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), (unknown), Oleg Demin	3
6	Two heads are better than one: current landscape of integrating QSP and machine learning 2022 ·Journal of Pharmacokinetics and Pharmacodynamics ·Tongli Zhang, (unknown), Peter L. Bonate, Limei Cheng, Tomáš Helikar, (unknown), Christopher Rackauckas, Kalyanasundaram Subramanian, Carolyn R. Cho, (unknown), (unknown), (unknown), Gordon Broderick, Valeriu Damian, Rafael Dariolli, Oleg Demin, (unknown), Dirk Fey, Abhishek Gulati, (unknown), Cynthia J. Musante, (unknown), Julio Sáez-Rodríguez, Eric A. Sobie	40
7	A Quantitative Systems Pharmacology (QSP) Model to Predict Receptor Occupancy of Bruton's Tyrosine Kinase (BTK) Inhibitors in Peripheral Blood Mononuclear Cells, Bone Marrow and Lymph Nodes of Patients with B-Cell Malignancies 2019 ·Blood ·Srikumar Sahasranaman, Oleg Demin, (unknown), (unknown), Nageshwar Budha, Ying Ou	1
8	A mathematical model of multisite phosphorylation of tau protein 2018 ·PLoS ONE ·Alexander A. Stepanov, (unknown), (unknown), Oleg Demin, Timothy Nicholas	20
9	Comprehensive study of the drug delivery properties of poly( l -lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice 2017 ·Journal of Controlled Release ·Vladimir Shalgunov, Daria Zaytseva‐Zotova, Arkadi Zintchenko, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Oleg Demin, Kevin McDonnell, Greg Troiano, Stephen E. Zale, (unknown)	52
10	Analysis of the efficacy of SGLT2 inhibitors using semi-mechanistic model 2014 ·Frontiers in Pharmacology ·Oleg Demin, (unknown), Dmitry Kolobkov	10
11	Kinetic modelling of central carbon metabolism in Escherichia coli 2012 ·FEBS Journal ·Kirill Peskov, (unknown), Oleg Demin	42
12	Reducing Systems Biology to Practice in Pharmaceutical Company Research; Selected Case Studies 2011 ·Advances in experimental medicine and biology ·Neil Benson, L. Cucurull-Sanchez, Oleg Demin, С. В. Смирнов, (unknown)	22
13	Kinetic Modeling as a Tool to Integrate Multilevel Dynamic Experimental Data 2009 ·Methods in molecular biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kirill Peskov, (unknown), Igor Goryanin, Oleg Demin	8
14	Kinetic modelling of NSAID action on COX-1: Focus on in vitro/in vivo aspects and drug combinations 2008 ·European Journal of Pharmaceutical Sciences ·Alexey Goltsov, (unknown), Maciej J. Swat, Yuri Kosinsky, (unknown), Oleg Demin, Igor Goryanin, (unknown)	17
15	Optimization of antimicrobial drug gramicidin S dosing regime using biosimulations 2008 ·European Journal of Pharmaceutical Sciences ·С. В. Смирнов, (unknown), Oleg Demin	7
16	Kinetic Model of Mitochondrial Krebs Cycle: Unraveling the Mechanism of Salicylate Hepatotoxic Effects 2006 ·Journal of Biological Physics ·(unknown), Oleg Demin, Igor Goryanin	30
17	Mathematical Modeling of Mitochondrial Adenine Nucleotide Translocase 2005 ·Biophysical Journal ·(unknown), Igor Goryanin, Oleg Demin	36
18	Analysis of Effects of 2,2',5,5'-Tetrachlorobiphenyl on the Flux Control in Oxidative Phosphorylation System in Rat Liver Mitochondria 2002 ·Molecular Biology Reports ·Vida Mildažienė, Zita Naučienė, Rasa Banienė, Oleg Demin, Klaas Krab	8
19	Kinetics and control of oxidative phosphorylation in rat liver mitochondria after chronic ethanol feeding 2000 ·Biochemical Journal ·(unknown), Vida Mildažienė, (unknown), Oleg Demin, Jan B. Hoek, Boris Ν. Kholodenko	33
20	Kinetic Mechanisms of Biological Regulation in Photosynthetic Organisms 1999 ·Journal of Biological Physics ·G. Yu. Riznichenko, (unknown), Oleg Demin, A. B. Rubin	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact